ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone. My name is Chelsea and I will be your conference operator.
Stay updated with breaking news from Call Transcript August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, everyone. My name is Chelsea and I will be your conference operator.
Operator: Good afternoon and welcome to the Energous Corporation Second Quarter 2023 Financial Results Earnings Conference Call. All participants will be in listen-only mode.
Operator: Good morning, ladies and gentlemen, my name is Abby, and I will be your conference operator today.
Anna Marie Wagner: Good evening. I am Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. I’m joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
Operator: Thank you for standing by, and welcome to MaxCyte's Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.